Lipo-C Peptide Side Effects: Not a Peptide, and What the Evidence Actually Shows
REVIEWED BY
Marcus Reinhardt — Chemical Researcher, Lead Analyst & Peptide Research Advisor
Marcus Reinhardt is a chemical researcher specializing in sustainable materials and advanced formulation science, with research experience in compound development and health optimization. He reviews all Peptide Insider educational content for scientific accuracy, strength of supporting evidence, and practical relevance. Editorial team.

Written by Marcus Reinhardt · Lead Analyst, Peptide Insider · LinkedIn
Evidence-first peptide coverage — every claim on this page is linked to its primary source and reviewed against our editorial policy
Citations verified against PubMed · Published: 2026-09-07 · Last updated: 2026-09-07
Lipo-C peptide side effects are a strange thing to research, because Lipo-C is not a peptide. It is a compounded injection built around methionine and choline, usually with inositol (the “MIC” trio), L-carnitine and often vitamin B12, sold by weight-loss clinics and, increasingly, by research vendors under codes like LC216 and LC526. No clinical trial of the blend has ever been published: a PubMed search for “lipotropic injection” returns nothing. What exists is a safety record for each ingredient on its own, mostly from oral supplementation, plus a large and unusually consistent body of self-reports from people injecting it alongside GLP-1 drugs. This page separates those three layers, cites every number, and does not pass off one for another.
Quick Answer: What the Lipo-C Side-Effect Data Actually Shows
There is no published human trial of Lipo-C, so there are no side-effect rates for the blend. The ingredients have individual records: L-carnitine’s three meta-analyses (up to 16,352 participants) report modest weight effects and no safety signal at oral doses of 150–4,000 mg/day (PMID 40298161); choline’s only trial-linked adverse event was a fishy body odor (PMID 26447156); inositol caused mild nausea, gas and diarrhea only at 12 g/day (PMID 21845803); methionine raises homocysteine acutely at loading doses (PMID 16702346); and injected B12 carries rare but documented anaphylaxis, benzyl-alcohol reactions and acne (PMID 25559140). What users themselves report most often is not any of that: it is injection pain, lumps and welts, followed by high B12 on bloodwork, heartburn, and sleep disruption. None of it has been measured against a placebo.
On our retatrutide and cagrilintide pages this box summarizes what hundreds of monitored trial participants went through. For Lipo-C the honest version is different: no group of people has ever received the blend under study conditions where side effects were recorded. The compounded product exists because a prescriber can order it, not because anyone tested it.
What monitored humans have received are the parts. Sixty children were randomized to 500 mg of choline a day or placebo for nine months, and the only adverse event linked to the choline was a fishy smell. Adults in 37 randomized trials took L-carnitine, mostly by mouth, and lost about a kilogram more than placebo. Two hundred and eighty-three older adults were randomized to oral or intramuscular B12, and the two routes produced comparable adverse effects, with 83% preferring the pill. Those are real experiences, carefully recorded, and none of them involved injecting the five ingredients together into a thigh twice a week.
Sources: PMID 26447156, PMID 32359762, PMID 32819927. When we publish an individual account here, it will be a real person, named with permission. We don’t write fiction into this slot.

Looking for Lab-Tested Peptides?
Our top-rated vendor does not sell Lipo-C, and we would not point you to a research-market version of an injectable vitamin blend (see the contamination reports below). For compounds that do have human weight-loss data, start with our retatrutide and tesamorelin coverage. Amino Club publishes batch COAs and third-party testing on every compound — get up to 30% off your first order.
Affiliate link — it doesn’t change what we report. All compounds sold strictly for non-human research use. Read our full Amino Club review.
In This Guide
- What Lipo-C Actually Is (and Why It Isn’t a Peptide)
- The “Lipotropic” Idea and Where It Comes From
- The Lipo-C Trial That Doesn’t Exist
- What Each Ingredient’s Human Data Shows
- Injection-Site Effects: The Best-Documented Side Effect Is the Needle
- Running B12 High
- What Users Report: Self-Reported Effects From Reddit
- Why “No Side Effects” From a Clinic Isn’t Data
- The Amounts on the Label vs the Amounts in the Trials
- Stacked With GLP-1s: The Most Common Pairing, Zero Studies
- Compounded vs Gray-Market Lipo-C: Where the Quality Risk Lives
- Sourcing and Verification
- US Regulatory Status
- Frequently Asked Questions
- Glossary of Terms
- References
What Lipo-C Actually Is (and Why It Isn’t a Peptide)
A peptide is a chain of amino acids joined by peptide bonds. Lipo-C contains amino acids and amino-acid derivatives, but none of them are joined to anything: it is a solution of free methionine (an amino acid), inositol (a sugar alcohol), choline (a nutrient related to the B vitamins), usually L-carnitine (made in the body from lysine and methionine), and in most versions vitamin B12, with B5, B6 or arginine appearing in some formulas. The name comes from “lipotropic”, a 1930s nutrition term for compounds that help the liver process fat, plus “C” for carnitine or choline depending on who is selling it. It is sold as a peptide because it is sold by the same telehealth clinics and research vendors that sell peptides, in the same vials, with the same syringes.
There is no single Lipo-C formula. The compounded version sold by two large 503A pharmacies is listed on their own pages as methionine 15 mg, choline chloride 50 mg, L-carnitine 50 mg and dexpanthenol 5 mg per millilitre, with no inositol and no B12 (checked September 7, 2026). Gray-market and clinic versions posted by users run much stronger: one label reads L-carnitine 200 mg, arginine 20 mg, methionine 25 mg, inositol 50 mg, choline 50 mg, dexpanthenol 25 mg, pyridoxine 25 mg and methylcobalamin 1 mg per millilitre (r/Biohackers); a MIC B12 product was quoted as 25 mg, 50 mg, 50 mg and 400 mcg per millilitre (r/PeptideForum). The spread matters for side effects: the ingredient users most often blame for injection pain, L-carnitine, ranges from 50 to 300 mg per millilitre across these labels, and the B12 that shows up in users’ bloodwork is in some versions and not others.
The “Lipotropic” Idea and Where It Comes From
Methionine, choline and inositol were called lipotropic factors because, in mid-century animal nutrition, diets deficient in them produced fatty livers and adding them back reversed it. That is a statement about deficiency, not about supplementation in people who are not deficient, and the leap from “prevents fatty liver in choline-deficient rats” to “burns fat when injected into a well-fed adult” has never been tested. L-carnitine has a more direct rationale, since it shuttles fatty acids into mitochondria to be burned, and it is the one ingredient with human weight-loss trials, discussed below. Vitamin B12 is included for the energy that a deficient person feels when replaced; in someone with normal B12, the trials of oral versus injected replacement offer no reason to expect an effect.
KEY TAKEAWAY
Lipo-C’s side effects are the sum of three things: the ingredients (each with its own, mostly oral, safety record), the route (a 1 mL intramuscular or subcutaneous injection of a concentrated, preserved solution), and the product (a compounded or gray-market vial with no published quality data). The clinic websites describe the first as harmless, skip the second, and never mention the third. Users’ reports are dominated by the second and third.
The Lipo-C Trial That Doesn’t Exist
We searched PubMed for “lipotropic injection” and “lipotropic injections” as title or abstract terms: zero results. The combination of methionine, inositol and choline with “injection” or “weight loss” returns a single unrelated liver-fibrosis paper. Searching for Lipo-C by name returns a 1995 liposome chemotherapy study. There is no randomized trial, no case series, no pharmacokinetic study and no adverse-event table for the blend, whether from a compounding pharmacy, a med spa or a research vendor. Every clinic page that lists Lipo-C side effects as “mild and rare” is describing an expectation, not a measurement.
We checked the claim that comes closest to data. The Lipo-C page of one of the largest compounding pharmacies states that “in a retrospective series of over 2,000 compounded lipotropic injections” systemic hypersensitivity was below 0.1 percent, and cites a 2023 allergy-journal paper with a PubMed ID. That PubMed ID resolves to a paper on benzene and toluene in sunscreen. Of the ten PubMed links in that page’s reference list that we checked, none led to the paper described; one, given as a 2015 “retrospective analysis” of lipotropic-injection safety, leads to a case report about a placental infarction. We mention this not to single out one pharmacy but because that reference list is, as far as we can find, the only place on the web where Lipo-C safety data is claimed to exist, and it does not.
That absence is the first thing to hold onto when reading anything else on this page, including our own component-by-component summary. Ingredient data can tell you what a nutrient does at a given oral dose in a given population. It cannot tell you what happens when five of them are combined, preserved with benzyl alcohol, and injected twice a week by someone who is also on tirzepatide.
What Each Ingredient’s Human Data Shows
The table below is the actual evidence base, one ingredient at a time. Note the routes and doses: almost all of it is oral, and several of the trial doses are ten to a hundred times what a millilitre of Lipo-C contains.
| Ingredient | Best human evidence | Side effects recorded | Source |
|---|---|---|---|
| L-carnitine | Three meta-analyses of oral supplementation: 9 RCTs, 911 adults, −1.33 kg vs control; 37 RCTs, 2,292 participants, −1.21 kg, maximum effect at about 2,000 mg/day; an umbrella review of eight meta-analyses, 16,352 participants, doses 150–4,000 mg/day for 8–30 weeks, weight effect size −1.11 | None reported in the abstracts; the effect on weight shrank with longer use in the 2016 analysis | PMID 27335245, PMID 32359762, PMID 40298161 |
| Choline | Two randomized placebo-controlled trials of 500 mg/day by mouth for 9 months in children with fetal alcohol spectrum disorders (n = 20 and n = 60) | Adverse events equal between arms except a fishy body odor, which occurred only in the choline groups; no serious adverse events | PMID 24176229, PMID 26447156 |
| Inositol | Safety review of myo-inositol in clinical use (mainly PCOS), oral | Only the highest dose, 12 g/day, produced mild gastrointestinal effects (nausea, flatus, diarrhea); severity did not rise with dose | PMID 21845803 |
| Methionine | Toxicity review; methionine-loading studies (0.1 g/kg by mouth) | Loading doses raise plasma homocysteine acutely and impair endothelial function for hours; a tenfold overdose given by mistake was fatal; intakes above five times normal raised homocysteine; effects moderated by B6, B12, folate and vitamin C | PMID 16702346, PMID 18838525 |
| Vitamin B12 | Randomized trial of oral vs intramuscular B12 in 283 adults over 65 with deficiency; 2025 meta-analysis of 16 studies, 6,098 participants, oral/sublingual vs injection | Adverse effects comparable between routes; 83.4% preferred oral. Case reports of anaphylaxis after intramuscular cyanocobalamin and of reactions to the benzyl alcohol preservative; a dermatology review lists acne, rosacea, injection-site allergy and anaphylaxis as complications of cobalamin therapy | PMID 32819927, PMID 41487531, PMID 15960291, PMID 15291924, PMID 25559140 |
Read as a whole, the ingredient record is reassuring in one direction and useless in another. At the amounts a millilitre of Lipo-C delivers, none of the five components comes close to the doses at which their own trials recorded side effects: 25 to 50 mg of inositol against a 12 g/day threshold, 25 mg of methionine against a 7 g loading dose for a 70 kg adult. The methionine concern in particular is a concern about grams by mouth, not milligrams by injection. What the record cannot address is the route, the preservative, the volume, and the combination, and those are exactly where users’ reports cluster.
PERSONAL OBSERVATION — PI EDITORIAL
Researching this page we read the compounding-pharmacy and clinic pages that rank on Google’s first page for “lipo c peptide”. They agree with each other closely: injection-site reactions, nausea, loose stools, headache, a fishy body odor, rare allergic reaction. To their credit, none of them calls Lipo-C a peptide, and one telehealth guide says outright that no trial of the blend exists. What struck us is what the lists leave out. Prolonged burning with lumps and welts, and B12 running far above range on bloodwork, are the two effects that dominate user reports, both are predictable from the labels, and neither appears on a single sales page we read. The one page that claimed actual safety data cited references we could not verify (see above).
Injection-Site Effects: The Best-Documented Side Effect Is the Needle
Lipo-C is a concentrated solution, typically injected at 1 mL, and most compounding pharmacies label it for intramuscular use with a 1-inch needle. That already makes it a different experience from a 10-unit subcutaneous peptide shot, and it is the experience users describe most. In the threads we read, burning at the site was the single most common complaint, with the intensity ranging from a passing sting to descriptions that would be hyperbole if they were not so consistent, and it was attributed by users to L-carnitine specifically: the formula with more carnitine stings more, and people who inject carnitine alone describe the same burn (r/PeptideGuide, r/Biohacking). Lumps under the skin, welts and itching after subcutaneous injection, bruising and occasional bleeding from intramuscular attempts, and hematomas from a thick formulation all recur across threads (r/joinrift, r/Peptidesource).
Two documented mechanisms sit behind the anecdotes. Hypertonic, acidic or high-volume injections are irritating regardless of what is in them, and L-carnitine injection at hundreds of milligrams per millilitre is all three. Separately, multi-dose vials of injectable B12 are preserved with benzyl alcohol, and hypersensitivity to that preservative, presenting as reactions at the injection site, is documented in the B12 literature going back decades (PMID 15291924). Lipo-C multi-dose vials use the same preservative system. A user whose eczema returned while using Lipo-C and faded each time they stopped, and another with itchy scalp bumps on a B12-containing version, describe exactly the pattern a preservative or ingredient sensitivity would produce, though neither was ever tested (r/PeptideGuidesPH).
PRACTICAL NOTES — WHAT CLINICAL PRACTICE DOES WITH INJECTABLE VITAMIN BLENDS
- Compounding pharmacies label MIC/Lipo-C for intramuscular use in a large muscle (gluteal, deltoid, lateral thigh) and supply 1-inch needles for that reason; subcutaneous use is off-label to the pharmacy’s own instructions
- Multi-dose vials are stored at room temperature, away from light, and discarded at the beyond-use date on the pharmacy label; several users who refrigerated theirs reported strands or separation and were told by the community to discard
- Prescribers ordering B12 injections check a baseline level first; the users who found their B12 “off the charts” were the ones who had not
- Our bacteriostatic water guide covers what benzyl alcohol is and why it is in multi-dose vials
Running B12 High
A millilitre of a B12-containing Lipo-C carries about 1 mg of cobalamin, the same amount as a full therapeutic B12 injection. Taken twice a week, that is eight replacement doses a month in someone who was never deficient. Three users in one thread described bloodwork after two to three months on that schedule: B12 far above the reference range, in one case over 2,000, with their physicians telling them to stop or cut back (r/Peptidesource); a fourth, in an earlier thread, was told the same about B vitamins generally (r/Peptidesource). High serum B12 from supplementation is not itself established as harmful, and the trials of oral versus injected replacement found comparable adverse effects between routes (PMID 32819927). But the dermatology literature does connect cobalamin therapy to acne and rosacea flares (PMID 25559140), and one user’s reason for abandoning a B12-containing blend was exactly that: breakouts (r/compoundedtirzepatide). The meta-analysis point that matters here is that oral and injected B12 raise levels equally well (PMID 41487531): whatever Lipo-C’s B12 is doing for energy, a tablet would do the same without the needle.
What Users Report: Self-Reported Effects From Reddit
Because no trial of Lipo-C exists, the only descriptions of what it does to a person are self-reports. We searched Reddit on September 7, 2026, found 97 relevant posts from 2023 to 2026, and read the full comment threads of 18, across r/Peptidesource, r/tirzepatidecompound, r/compoundedtirzepatide, r/Biohacking, r/Biohackers, r/PeptideGuide, r/PeptideForum, r/Retatrutide, r/PeptidePathways, r/joinrift and r/PeptideGuidesPH. Everything below is paraphrased and linked, uses no usernames, and describes products nobody verified. Almost every poster was also on tirzepatide, semaglutide or retatrutide and took Lipo-C for the fatigue those drugs cause, so nothing here separates the blend’s effects from the GLP-1’s.
Injection pain is the dominant report. Burning during and after the shot, described in a third or more of the threads, sometimes lasting the day, with lumps, welts, itching and bruising at the site; users blame L-carnitine, dilute the solution, inject over several minutes, apply lidocaine, or move from thigh to glute or deltoid to manage it (r/Biohacking, r/Biohackers, r/PeptideForum). One poster gave up a stronger version because it “burned insanely bad” (r/Retatrutide).
Skin reactions. A returning eczema flare that tracked use and stopping; itchy scalp bumps attributed by the poster to the B12; a welt reaction that appeared only after switching to a formula with double the B6 and more carnitine; acne from B12-containing blends (r/PeptideGuidesPH, r/Biohackers, r/compoundedtirzepatide).
Bloodwork. Very high B12 after two to three months of twice-weekly use, with physicians advising a stop, from several independent posters (r/Peptidesource).
Gut and sleep. Heartburn that started after about a week, resolved on stopping and returned on re-trying, which the poster attributed to carnitine; gas on injection days from two posters; insomnia when injected on dose night or late morning, and feeling “wired” at a higher amount, leading several to cut frequency; first-time dizziness, headache and nausea in one poster who later tolerated it (r/tirzepatidecompound, r/PeptideForum, r/Peptidesource).
The effect people wanted splits almost evenly. Many describe a lift in energy against GLP-1 fatigue, arriving within an hour or two and lasting the day, and a few credit it with breaking a weight stall (r/JoinMochiHealth, r/PeptideGuidesPH). As many describe nothing at all, including one poster who used it for 18 weeks with no positive or negative effect and several who call it junk or “50/50” (r/compoundedtirzepatide, r/Retatrutide). The one recurring caveat from the sceptics is worth repeating: people who were not vitamin-deficient noticed the least.
Product integrity. A poster whose ten gray-market vials all developed strands was told by dozens of replies to discard them as contaminated; another posted a yellow liquid that the community concluded was not Lipo-C at all; and multiple threads carry the warning that gray-market injectable vitamins have a history of testing as dyed sterile water (r/Peptidesource, r/PeptidePathways). One telehealth customer received compounded product nine months after its compounding date (r/Peptidesource).
What this is and is not: a map of what people say happens, weighted toward those who had something to say. It is not a rate, not a comparison to placebo, and not a verification of what was in anyone’s vial.
Why “No Side Effects” From a Clinic Isn’t Data
A telehealth clinic that has dispensed Lipo-C to thousands of customers and heard few complaints is not in possession of a safety dataset. Nobody was asked systematically; nobody was compared to a group given saline; nobody’s B12 or homocysteine was measured before and after; and a customer who stopped because of heartburn or an eczema flare simply did not reorder. Pharmacovigilance for compounded products is nearly nonexistent, since there is no manufacturer to receive adverse-event reports and no label to update. The user reports above exist precisely because there is nowhere official for them to go. That is why this page treats the absence of an adverse-event table as an absence of surveillance, not as a clean result.
The Amounts on the Label vs the Amounts in the Trials
Lipo-C labels state milligrams per millilitre, and clinics generally instruct 1 mL once or twice a week; users describe schedules from 0.25 mL twice weekly to 1 mL three times a week. Set the labelled amounts against the trial doses and the picture is lopsided. The L-carnitine meta-analysis found its maximum weight effect at about 2,000 mg a day by mouth (PMID 32359762); a millilitre of a 200 mg/mL blend delivers a tenth of that, once or twice a week, by a route with different absorption. Inositol’s side effects appeared at 12 g a day; a millilitre carries 50 mg. The exception runs the other way: 1 mg of injected B12 per millilitre is a full replacement dose, so twice-weekly use is a lot of B12 for someone who does not need any.
DID YOU KNOW
The 2016 carnitine meta-analysis found that the weight-loss effect got smaller the longer people took it (PMID 27335245), and the 2020 analysis found that only the highest-quality trials confirmed an effect on body weight at all, with none on waist circumference or body-fat percentage (PMID 32359762). The best-evidenced ingredient in Lipo-C is evidenced for about a kilogram, fading, by mouth.
None of this is a dose recommendation; Peptide Insider does not give one for any compound. It is arithmetic on published labels and published trials, and our peptide calculator handles the millilitre-to-unit conversion for anyone who wants it.
Stacked With GLP-1s: The Most Common Pairing, Zero Studies
In the threads we read, Lipo-C was almost never used alone. Its market is people on tirzepatide, semaglutide or retatrutide who want relief from the fatigue those drugs produce, and clinics sell it as an add-on to the GLP-1 prescription. There is no study of the combination. Two things are worth knowing anyway. First, the GLP-1 drugs have their own well-measured gastrointestinal side-effect profile, so heartburn or nausea that appears after adding Lipo-C cannot be attributed to either drug without stopping one; the poster whose reflux resolved and recurred on re-challenge did the closest thing to a controlled test anyone in these threads managed. Second, several users report stacking Lipo-C with NAD+, GHK-Cu, KLOW, MOTS-c or SS-31 in the same week, which makes any report about any single compound uninterpretable. Our MOTS-c and KLOW pages cover what those compounds’ own evidence looks like.
Compounded vs Gray-Market Lipo-C: Where the Quality Risk Lives
Lipo-C reaches people by two routes with very different risk profiles. Compounded product comes from a licensed 503A pharmacy on a prescription, is made under pharmacy sterility standards, carries a beyond-use date, and can be traced if something goes wrong; its limitation is that the formula itself was never tested. Gray-market product, sold by research vendors under codes like LC216, LC526 or “Fat Blaster” and often shipped pre-mixed, has neither the testing nor the traceability, and injectable aqueous vitamin solutions are a worse candidate for that market than lyophilized peptides, because a pre-mixed water-based vial can grow things. The Reddit record bears this out: the contamination and wrong-product threads are all gray-market, and even users who defend gray-market peptides in general warn against gray-market lipos specifically (r/PeptidePathways).
PERSONAL OBSERVATION — PI EDITORIAL
We review research-vendor listings for a living, and Lipo-C listings are the only place we regularly see a product code stand in for an ingredient list. A vial labelled LC526 with no per-millilitre breakdown cannot be assessed for anything on this page: not the carnitine that stings, not the B12 that accumulates, not the preservative that sensitizes. A certificate of analysis for a five-ingredient aqueous blend would need to quantify five compounds and confirm sterility; we have not yet seen a gray-market listing that provides one. Until we do, we will not link to a research-market Lipo-C, which is why the vendor box on this page points elsewhere.
Sourcing and Verification
If Lipo-C is obtained at all, the prescription route is the one the evidence on this page supports, for the mundane reason that it is the only route with a sterile-compounding standard, an ingredient list, and someone accountable. A prescriber should be checking a baseline B12 and, given the methionine, ideally homocysteine. On the research market, the minimum before a vial is considered is the same as for any compound on this site: a batch-matched certificate of analysis that quantifies every listed ingredient and includes a sterility or endotoxin result, as explained in our guide to reading a COA. A listing that provides only a code and a colour does not meet it. Our vendor comparisons cover which research vendors publish testing at all; none we cover lists Lipo-C.
US Regulatory Status
Lipo-C is not an FDA-approved drug. It exists as a compounded preparation, made to order by 503A pharmacies under a prescription, which places it outside the approval process that generates safety labelling. Its ingredients are individually familiar to regulators, and cyanocobalamin injection in particular is an approved prescription product with its own labelling, which is where the anaphylaxis and benzyl-alcohol warnings in the B12 literature come from. Research vendors selling pre-mixed Lipo-C “for research use” are selling an injectable vitamin solution under a label that is meant for compounds with laboratory uses; there is no laboratory use for a pre-mixed MIC injection, and the FDA’s warning letters to peptide vendors have made clear that the label does not change what a product is.
Frequently Asked Questions
What are the side effects of Lipo-C injections?
No trial has measured them. From the ingredients’ own records, the documented possibilities are injection-site reactions and rare anaphylaxis with injected B12, acne or rosacea with cobalamin therapy, and gastrointestinal effects from inositol only at doses far above a millilitre’s content. From user reports, the common ones are burning and lumps at the injection site, high B12 on bloodwork, heartburn, gas and disturbed sleep.
Is Lipo-C a peptide?
No. It is a solution of free amino acids and nutrients (methionine, inositol, choline, usually L-carnitine and vitamin B12). Nothing in it is a peptide chain. It is sold alongside peptides by the same clinics and vendors, which is where the name “Lipo-C peptide” comes from.
Why does Lipo-C burn when injected?
Users overwhelmingly attribute it to the L-carnitine, which is present at 200 mg or more per millilitre in many formulas; versions with more carnitine are reported to burn more, and carnitine injected alone produces the same effect. Concentrated, high-volume injections are irritating in general, and pharmacies label the product for intramuscular use partly for that reason.
Can Lipo-C raise your B12 too high?
Each millilitre of a B12-containing version carries about 1 mg of cobalamin, a full replacement dose, and several users describe B12 far above the reference range after two to three months of twice-weekly use, with their physicians telling them to stop. High supplemental B12 is not established as harmful in itself, but cobalamin therapy is linked to acne and rosacea flares, and oral B12 raises levels just as effectively without the injection.
Does Lipo-C help with weight loss?
There is no trial of Lipo-C. Its best-evidenced ingredient, L-carnitine, produced about a kilogram more weight loss than placebo in meta-analyses of oral supplementation at up to 2,000 mg a day, an effect that shrank with longer use; a millilitre of Lipo-C contains a tenth of that dose. Methionine, inositol and choline have no human weight-loss data. Users on GLP-1 drugs split roughly evenly between describing an energy lift and describing nothing.
Is gray-market Lipo-C safe?
It is the highest-risk form of the product. Pre-mixed aqueous vitamin solutions can support microbial growth, and Reddit threads document vials with visible strands, products that were not Lipo-C at all, and community warnings that gray-market lipos have tested as dyed water. No research-vendor listing we have seen publishes a certificate quantifying all ingredients plus sterility.
Glossary of Terms
- Lipo-C: a compounded or gray-market injection of methionine, inositol and choline, usually with L-carnitine and vitamin B12; not a peptide.
- MIC: methionine, inositol, choline; the “lipotropic” trio at the core of every Lipo-C and Lipo-B formula.
- Lipotropic: a mid-20th-century nutrition term for compounds that prevent fat accumulation in the liver of deficient animals.
- 503A compounding pharmacy: a state-licensed pharmacy that prepares individual prescriptions, including Lipo-C, outside the FDA approval process.
- Benzyl alcohol: the preservative in multi-dose injectable vials, including B12 and bacteriostatic water; a documented cause of injection-site hypersensitivity.
- Homocysteine: an amino acid produced from methionine; elevated levels are a cardiovascular risk marker, and methionine loading raises them acutely.
- Beyond-use date: the compounding-pharmacy equivalent of an expiry date, after which sterility and potency are not assured.
References
- Pooyandjoo M, et al. The effect of (L-)carnitine on weight loss in adults: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2016. PMID 27335245
- Talenezhad N, et al. Effects of l-carnitine supplementation on weight loss and body composition: a systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis. Clin Nutr ESPEN. 2020. PMID 32359762
- The Effect of the L-Carnitine Supplementation on Obesity Indices: An Umbrella Meta-Analysis. Int J Vitam Nutr Res. 2025. PMID 40298161
- Wozniak JR, et al. Choline supplementation in children with fetal alcohol spectrum disorders has high feasibility and tolerability. Nutr Res. 2013. PMID 24176229
- Wozniak JR, et al. Choline supplementation in children with fetal alcohol spectrum disorders: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2015. PMID 26447156
- Carlomagno G, Unfer V. Inositol safety: clinical evidences. Eur Rev Med Pharmacol Sci. 2011. PMID 21845803
- Garlick PJ. Toxicity of methionine in humans. J Nutr. 2006. PMID 16702346
- Methionine-loading rapidly impairs endothelial function, by mechanisms independent of endothelin-1. J Am Coll Nutr. 2008. PMID 18838525
- Sanz-Cuesta T, et al. Oral versus intramuscular administration of vitamin B12 for vitamin B12 deficiency in primary care: a pragmatic, randomised, non-inferiority clinical trial (OB12). BMJ Open. 2020. PMID 32819927
- Efficacy of sublingual and oral vitamin B12 versus intramuscular administration: a systematic review and meta-analysis. Front Pharmacol. 2025. PMID 41487531
- Bilwani F, et al. Anaphylactic reaction after intramuscular injection of cyanocobalamin (vitamin B12): a case report. J Pak Med Assoc. 2005. PMID 15960291
- Adverse reactions to vitamin B12 injections due to benzyl alcohol sensitivity: successful treatment with intranasal cyanocobalamin. Allergy. 2004. PMID 15291924
- Brescoll J, Daveluy S. A review of vitamin B12 in dermatology. Am J Clin Dermatol. 2015. PMID 25559140
- Reddit threads cited inline were read on September 7, 2026; the search and thread log is kept in our editorial records.